Cargando...
Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?
Mesenchymal stromal cells (MSCs) are under active consideration as a treatment strategy for controlling the hyper-inflammation and slow disease progression associated with coronavirus disease 2019 (COVID-19). The possible mechanism of protection through their immunoregulatory and paracrine action ha...
Gardado en:
| Publicado en: | Cytotherapy |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8084615/ https://ncbi.nlm.nih.gov/pubmed/34053857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2021.04.004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|